Research section
Induction of rat hepatic cytochrome P-450 I proteins by the antimutagen anthraflavic acid

https://doi.org/10.1016/0278-6915(88)90088-9Get rights and content

Abstract

Administration of the antimutagen anthraflavic acid to rats gave rise to significant increases in the hepatic microsomal O-deethylations of ethoxyresorufin and ethoxycoumarin, but not in the O-dealkylation of pentoxyresorufin nor in cytosolic glutathione S-transferase activity. Immunoblot studies of solubilized microsomes from anthraflavic acid-treated rats revealed that anthraflavic acid induced the apoproteins P-450 I A1 and A2 but not P-450 B1 and B2. Pretreatment with anthraflavic acid resulted in a marked increase in the in vitro bioactivation of 2-amino-6-methyldipyrido[1,2-a:3′,2′-d]imidazole and 2-amino-3,2-amino-3-methylimidazomethylimidazo[4,5-ƒ]-quinoline (IQ) to mutagenic intermediate(s); IQ is a carcinogen against which anthraflavic acid has displayed strong antimutagenic effect in the Ames test when incorporated into the metabolic activation system. The increase in mutagenicity of IQ was the result of enhancement of both the microsomal and cytosolic activation steps. It is concluded that anthraflavic acid is a specific inducer of P-450 I proteins in the rat and this compound is not only unlikely to exhibit any anticarcinogenic effect in vivo but may act as a co-carcinogen.

References (33)

  • A.D. Rodrigues et al.

    Induction of the rat hepatic microsomal mixed-function oxidases by 3-imidazole-containing antifungal agents: selectivity for the cytochrome P450 II B and P450 III families of cytochromes P-450

    Toxicology

    (1988)
  • C.H. Williams et al.

    Microsomal triphosphopyridine nucleotide cytochrome c reductase of liver

    J. biol. Chem.

    (1962)
  • A. Abu-Shakra et al.

    Metabolic activation of 2-amino-3-methylimidazo[4,5-ƒ]-quinoline by hepatic preparations—contribution of the cytosolic fraction and its significance to strain differences

    Mutagenesis

    (1986)
  • B.N. Ames

    Cancer and diet

    Science, N.Y.

    (1984)
  • M.D. Burke et al.

    Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene

    Drug Metab. Dispos.

    (1974)
  • M. Das et al.

    Effect of ellagic acid on hepatic and pulmonary xenobiotic metabolism in mice

  • Cited by (15)

    • Heterogenous effects of anthraquinones on drug-metabolizing enzymes in the liver and small intestine of rat

      2000, Chemico-Biological Interactions
      Citation Excerpt :

      So far no information is available on the potential of AQs to induce P450 1A or other drug-metabolizing enzymes in the intestine and little is known on the modulation of these enzymes in the liver. Ioannides et al. [16,17] reported that the 2,6-dihydroxyanthraquinone was able to enhance the hepatic EROD activity and the apoprotein levels of both 1A1 and 1A2 in rat but it was not ascertained if the transcriptional of P450 1A1 or 1A2 mRNA or both were induced. The induction by AQs of P450 1A2 but not P450 1A1 is possible since in mice the administration of various tricyclic PAHs induces only 1A2 [18].

    • Consumption of tea modulates the urinary excretion of mutagens in rats treated with IQ. Role of caffeine

      1999, Mutation Research - Genetic Toxicology and Environmental Mutagenesis
    View all citing articles on Scopus
    View full text